Pavle R.
- Country
- Croatia
- Department
- Hematology
Research Overview
Data & Insights
Has run more than one trial at 0 of 119 partner sites.
Specializations
Hematologic Malignancies
The investigator specializes in the treatment of myeloproliferative neoplasms, with particular emphasis on primary myelofibrosis and secondary myelofibrosis conditions.
- Primary Myelofibrosis Management
- Post-Polycythemia Vera Myelofibrosis
- Post-Essential Thrombocythemia Myelofibrosis
Investigates novel therapeutic combinations involving JAK inhibitors for enhanced treatment outcomes in myelofibrosis patients.
Therapeutic Innovation
Focuses on developing innovative treatment approaches using targeted therapies for bone marrow disorders. Explores combination strategies with established treatments to improve patient outcomes.
- Spleen Volume Reduction Therapy
- Symptom Score Management
- Novel Drug Combinations
Specializes in evaluating therapeutic responses through clinical endpoints related to organ function and symptom improvement.
Clinical Assessment
Expertise in measuring therapeutic efficacy through comprehensive clinical assessments and objective response criteria in hematologic conditions.
- Spleen Response Evaluation
- Symptom Assessment
- Treatment Response Monitoring
Utilizes advanced methodologies to evaluate disease progression and treatment effectiveness in myelofibrosis patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.